ROSEN, NATIONAL TRIAL COUNSEL, Encourages Xponential Health, Inc. Traders to Inquire About Securities Class Motion Investigation – XPOF – Xponential Health (NYSE:XPOF)

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Legislation Agency, a worldwide investor rights regulation agency, publicizes an investigation of potential securities claims on behalf of shareholders of Xponential Health, Inc. (NYSE:XPOF) ensuing from allegations that Xponential Health could have issued materially deceptive enterprise info to the investing public.

SO WHAT: Should you bought Xponential Health securities chances are you’ll be entitled to compensation with out fee of any out of pocket charges or prices by way of a contingency price association. The Rosen Legislation Agency is getting ready a category motion searching for restoration of investor losses.


Enter your electronic mail and you will additionally get Benzinga’s final morning replace AND a free $30 reward card and extra!

WHAT TO DO NEXT: To hitch the potential class motion, go to or name Phillip Kim, Esq. toll-free at 866-767-3653 or electronic mail [email protected] or [email protected] for info on the category motion.

“The Finest Report Benzinga Has Ever Produced”

Large returns are potential inside this market! For a restricted time, get entry to the Benzinga Insider Report, often $47/month, for simply $0.99! Uncover extraordinarily undervalued inventory picks earlier than they skyrocket! Time is working out! Act quick and safe your future wealth at this unbelievable low cost! Declare Your $0.99 Provide NOW!



WHAT IS THIS ABOUT: On June 26, 2023, market analyst Fuzzy Panda Analysis issued a report entitled “Xponential Health (XPOF) – “Abusive Franchisor That Is A Home of Playing cards”. The report alleged that Xponential’s CEO, Anthony Geisler, “has a protracted historical past of deceptive buyers and enterprise companions”, together with partaking in pump and dump schemes. The report acknowledged that he’d been beforehand accused by former enterprise associates of partaking in “scams” and “unlawful enterprise practices”, and alleged that he has even prior to now threatened others with a gun. As well as, the report alleged that the corporate’s financials are much less wholesome than it has represented to buyers, that it’s doubtless violating its debt agreements, and, opposite to Geisler’s declare that Xponential has “by no means closed a retailer”, that there have been many closed Xponential places.

On this information, Xponential’s stpck fell $9.39 per share, or 37.40% to shut at $15.72 per share on June 27, 2023.

WHY ROSEN LAW: We encourage buyers to pick out certified counsel with a monitor document of success in management roles. Usually, companies issuing notices do not need comparable expertise, sources, or any significant peer recognition. Many of those companies don’t really litigate securities class actions. Be clever in deciding on counsel. The Rosen Legislation Agency represents buyers all through the globe, concentrating its follow in securities class actions and shareholder by-product litigation. Rosen Legislation Agency has achieved the biggest ever securities class motion settlement towards a Chinese language Firm. Rosen Legislation Agency was Ranked No. 1 by ISS Securities Class Motion Providers for variety of securities class motion settlements in 2017. The agency has been ranked within the prime 4 annually since 2013 and has recovered lots of of tens of millions of {dollars} for buyers. In 2019 alone the agency secured over $438 million for buyers. In 2020, founding associate Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Lots of the agency’s attorneys have been acknowledged by Lawdragon and Tremendous Legal professionals.

Comply with us for updates on LinkedIn:, on Twitter: or on Fb:

Lawyer Promoting. Prior outcomes don’t assure an analogous final result.


Contact Info:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Legislation Agency, P.A.
275 Madison Avenue, fortieth Flooring
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]

© 2023 Benzinga doesn’t present funding recommendation. All rights reserved.

Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *